At CENTOGENE, we understand that a timely and accurate diagnosis is crucial for patients and their families, especially when a long diagnostic odyssey spanning years and multiple misdiagnoses have taken place. That’s why we offer a comprehensive diagnostic portfolio that goes beyond standard laboratory testing and medical interpretation.
Our solutions are powered by the CENTOGENE Biodatabank, global clinical network, and deep medical expertise, as well as our proprietary CentoCard®-based sample logistics system. We aim to rapidly diagnose rare and neurodegenerative diseases – using our insights to provide actionable results for patients and physicians.
Our cutting-edge genetic and multiomic testing are at the heart of what we do – helping to deliver life-changing answers to patients around the world.
We offer the world’s largest genetic testing portfolio with 19,000 genes represented
Our tests offer a proven high diagnostic yield to enable an unparalleled level of certainty
We work with the hundreds of medical experts – meticulously interpreting, reviewing, and approving genetic lab results
Our multidimensional approach enables a complete clinical picture for the most holistic diagnosis, prognosis, and monitoring
We offer best-in-class medical reporting powered by the CENTOGENE Biodatabank with ~700,000 patients from >120 countries
Whole Genome Sequencing (WGS), offers the most comprehensive one-step solution with the highest diagnostic yield
Whole Exome Sequencing (WES) enables quicker and cost-effective diagnosis for patients with complex and unclear symptoms
Our NGS panel portfolio tests for a wide selection of hereditary genetic conditions offering a fast, thorough, and cost-effective diagnostic tool for patients with distinctive clinical features.
Customizable testing solution that enables physicians to have the flexibility to create a gene panel tailored to each patient’s clinical needs. #YourPatientYourChoice
Many genetic diseases are caused by changes or variants in a single gene. We offer a comprehensive range of tests for myriad single gene disorders.
Multiomics give a deeper understanding of human biological processes and acts as a unique and highly effective tool for early diagnosis
Non-invasive prenatal test (NIPT) that screens for the most common fetal chromosomal abnormalities – combining the latest NGS technology with expert medical reporting.
Our global network of customer support and experts guiding you every step of the way.
Send us a messageRegional Support
